r/shares – CRSP ostensibly cures affected person of sickle cell anemia, the primary gene enhancing remedy to remedy a Mendelian dysfunction


In a outstanding outcomes, CRSP exhibits that their gene enhancing remedy, utilizing the CRISPR-Cas9 expertise that just lately received its co-founder Emmanuelle Charpentier the 2020 Nobel Prize in chemistry, successfully cured one affected person of sickle cell anemia and one other of B-thalassemia. CRSP proclaims these leads to a chat on the American Society of Hematologists and in a publication within the premier medical journal- NEJM


That is the primary time gene enhancing has cured a genetic illness in sufferers.

CRSP and the opposite gene enhancing shares EDIT, NTLA, and BEAM have had nice runs this 12 months, and their expertise has now been validated in a landmark examine.


Please enter your comment!
Please enter your name here